September 25, 2017
College Park Marriott / Hyattsville, MD


Lupus PFDD LogoThe Lupus: Patient Voices report was composed as a result of the Externally-Led Lupus Patient-Focused Drug Development meeting, a parallel effort to the U.S. Food and Drug Administration’s (FDA) Patient-Focused Drug Development Initiative. This report includes data and personal accounts from people with lupus on symptoms, daily disease impacts, current treatments, and views on clinical trials.

The report has been shared directly with the Food and Drug Administration (FDA) and is considered patient experience data, meaning that it can be used by the FDA during the review and approval process of new drugs for lupus. We hope this report will help the FDA to better understand the perspectives and experiences of people with lupus and advance superior treatments for this devastating disease.